Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2022-11-04

Clinical Trial Update: Comparison of ISTp- PYRAMAX-US-RDT to IPTp-SP to Prevent Malaria in Pregnant Women in DRC (ULTRAPYRAPREG) [Phase 3]

View source ↗

Summary

Phase 3 trial comparing ISTp-PYRAMAX-US-RDT to IPTp-SP for malaria prevention in pregnant women in the Democratic Republic of Congo has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • IPTp-SP
  • ISTp-PYRAMAX-US-RDT

Snippet

Sponsor: University of Kinshasa | Conditions: Malaria in Pregnancy | Phase 3 | Status: COMPLETED